Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells

References

• Abu lila AS, Ichihara M, Shimizu T, Ishida T, Kiwada H. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome. Biol Pharm Bull, 2013a;36:1842–8
   PubMed Web of Science ®Google Scholar
• Abu lila AS, Kiwada H, Ishida T. The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage. J Control Release, 2013b;172:38–47
   PubMed Web of Science ®Google Scholar
• Bartucci R, Pantusa M, Marsh D, Sportelli L. Interaction of human serum albumin with membranes containing polymer-grafted lipids: Spin-label ESR studies in the mushroom and brush regimes. Biochim Biophys Acta, 2002;1564:237–42
   PubMed Web of Science ®Google Scholar
• Carafa M, Marianecci C, Lucania G, Marchei E, Santucci E. New vesicular ampicillin-loaded delivery systems for topical application: Characterization, in vitro permeation experiments and antimicrobial activity. J Control Release, 2004;95:67–74
   PubMed Web of Science ®Google Scholar
• Carafa M, Santucci E, Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: Characterization and in vitro permeation studies. Int J Pharm, 2002;231:21–32
   PubMed Web of Science ®Google Scholar
• Celia C, Calvagno MG, Paolino D, Bulotta S, Ventura CA, Russo D, Fresta M. Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes. J Nanosci Nanotechnol, 2008;8:2102–13
   PubMed Web of Science ®Google Scholar
• Celia C, Trapasso E, Locatelli M, Navarra M, Ventura CA, Wolfram J, Carafa M, Morittu VM, Britti D, Di marzio L, Paolino D. Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells. Colloids Surf B Biointerfaces, 2013;112:548--53
   PubMed Web of Science ®Google Scholar
• Chang HI, Yeh MK. Clinical development of liposome-based drugs: Formulation, characterization, and therapeutic efficacy. Int J Nanomedicine, 2012;7:49–60
   PubMed Web of Science ®Google Scholar
• Cosco D, Bulotta A, Ventura M, Celia C, Calimeri T, Perri G, Paolino D, Costa N, Neri P, Tagliaferri P, et al. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer. Cancer Chemother Pharmacol, 2009a;64:1009–20
   PubMed Web of Science ®Google Scholar
• Cosco D, Paolino D, Muzzalupo R, Celia C, Citraro R, Caponio D, Picci N, Fresta M. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil. Biomed Microdevices, 2009b;11:1115–25
   PubMed Web of Science ®Google Scholar
• Dai Y, Desano J, Tang W, Meng X, Meng Y, Burstein E, Lawrence TS, Xu L. Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB. PLoS One, 2010;5:e14153
   PubMed Web of Science ®Google Scholar
• Dai Y, Desano JT, Meng Y, Ji Q, Ljungman M, Lawrence TS, Xu L. Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer. Int J Radiat Oncol Biol Phys, 2009;74:1217–25
   PubMed Web of Science ®Google Scholar
• Gentile E, Cilurzo F, Di marzio L, Carafa M, Ventura CA, Wolfram J, Paolino D, Celia C. Liposomal chemotherapeutics. Future Oncol, 2013;9:1849--59
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhou D, Hang T, Wu Z, Liu J, Xu Q, Xie X, Zuo J, Wang Z, Zhou Y. Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol. Anticancer Drugs, 2012;23:515–24
   PubMed Web of Science ®Google Scholar
• Hupfeld S, Moen HH, Ausbacher D, Haas H, Brandl M. Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: Influence of ionic strength and osmotic pressure of the carrier liquid. Chem Phys Lipids, 2010;163:141–7
   PubMed Web of Science ®Google Scholar
• Ichihara M, Moriyoshi N, Lila AS, Ishida T, Kiwada H. Anti-PEG IgM production via a PEGylated nano-carrier system for nucleic acid delivery. Methods Mol Biol, 2013;948:35–47
   PubMedGoogle Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine, 2006;1:297–315
   PubMed Web of Science ®Google Scholar
• Kaufmann S, Borisov O, Textor M, Reimhult E. Mechanical properties of mushroom and brush poly(ethylene glycol)-phospholipid membranes. Soft Matter, 2011;7:9267–75
   Web of Science ®Google Scholar
• Kim HR, Andrieux K, Delomenie C, Chacun H, Appel M, Desmaele D, Taran F, Georgin D, Couvreur P, Taverna M. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system. Electrophoresis, 2007;28:2252–61
   PubMed Web of Science ®Google Scholar
• Koudelka S, Turanek J. Liposomal paclitaxel formulations. J Control Release, 2012;163:322–34
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting. J Control Release, 2010;145:178–81
   PubMed Web of Science ®Google Scholar
• Liang X, Mao G, Ng KY. Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy. J Colloid Interface Sci, 2004;278:53–62
   PubMed Web of Science ®Google Scholar
• Liu Z, Ma L, Zhou GB. The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules, 2011;16:5283–97
   PubMed Web of Science ®Google Scholar
• Molinaro R, Wolfram J, Federico C, Cilurzo F, Di Marzio L, Ventura CA, Carafa M, Celia C, Fresta M. Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors. Expert Opin Drug Deliv, 2013;10(12):1653--68
   PubMed Web of Science ®Google Scholar
• Montaguti P, Melloni E, Cavalletti E. Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Arzneimittelforschung, 1994;44:566–70
   PubMed Web of Science ®Google Scholar
• Paolino D, Cosco D, Racanicchi L, Trapasso E, Celia C, Iannone M, Puxeddu E, Costante G, Filetti S, Russo D, Fresta M. Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: Biodistribution, pharmacokinetic features and in vivo antitumor activity. J Control Release, 2010;144:144–50
   PubMed Web of Science ®Google Scholar
• Parr MJ, Ansell SM, Choi LS, Cullis PR. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim Biophys Acta, 1994;1195:21–30
   PubMed Web of Science ®Google Scholar
• Pasut G, Veronese FM. State of the art in PEGylation: The great versatility achieved after forty years of research. J Control Release, 2012;161:461–72
   PubMed Web of Science ®Google Scholar
• Pencer J, White GF, Hallett FR. Osmotically induced shape changes of large unilamellar vesicles measured by dynamic light scattering. Biophys J, 2001;81:2716–28
   PubMed Web of Science ®Google Scholar
• Pulini S, Rupoli S, Goteri G, Pimpinelli N, Alterini R, Bettacchi A, Mulattieri S, Picardi P, Tassetti A, Scortechini AR, et al. Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. Eur J Haematol, 2009;82:184–93
   PubMed Web of Science ®Google Scholar
• Rubin LF. Toxicity of dimethyl sulfoxide, alone and in combination. Ann N Y Acad Sci, 1975;243:98–103
   PubMed Web of Science ®Google Scholar
• Ruiz-Delgado GJ, Mancias-Guerra C, Tamez-Gomez EL, Rodriguez-Romo LN, Lopez-Otero A, Hernandez-Arizpe A, Gomez-Almaguer D, Ruiz-Arguelles GJ. Dimethyl sulfoxide-induced toxicity in cord blood stem cell transplantation: Report of three cases and review of the literature. Acta Haematol, 2009;122:1–5
   PubMed Web of Science ®Google Scholar
• Sabin J, Prieto G, Ruso JM, Hidalgo-alvarez R, Sarmiento F. Size and stability of liposomes: A possible role of hydration and osmotic forces. Eur Phys J E Soft Matter, 2006;20:401–8
   PubMed Web of Science ®Google Scholar
• Schroit AJ, Fidler IJ. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide. Cancer Res, 1982;42:161–7
   PubMed Web of Science ®Google Scholar
• Sethi G, Ahn KS, Pandey MK, Aggarwal BB. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood, 2007;109:2727–35
   PubMed Web of Science ®Google Scholar
• Shao L, Zhou Z, Cai Y, Castro P, Dakhov O, Shi P, Bai Y, Ji H, Shen W, Wang J. Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-kappaB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer. PLoS One, 2013;8:e58391
   PubMed Web of Science ®Google Scholar
• Song J, Shi F, Zhang Z, Zhu F, Xue J, Tan X, Zhang L, Jia X. Formulation and evaluation of celastrol-loaded liposomes. Molecules, 2011;16:7880–92
   PubMed Web of Science ®Google Scholar
• Swanson BN. Medical use of dimethyl sulfoxide (DMSO). Rev Clin Basic Pharmacol, 1985;5:1–33
   PubMedGoogle Scholar
• Vogin EE, Carson S, Cannon G, Linegar CR, Rubin LF. Chronic toxicity of DMSO in primates. Toxicol Appl Pharmacol, 1970;16:606–12
   PubMed Web of Science ®Google Scholar
• Wolfram J, Suri K, Yang Y, Shen J, Celia C, Fresta M, Zhao Y, Shen H, Ferrari M. Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids Surf B Biointerfaces, 2013;114C:294–300
   Google Scholar
• Yang H, Chen D, Cui QC, Yuan X, Dou QP. Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res, 2006;66:4758–65
   PubMed Web of Science ®Google Scholar